Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-23

Clinical Trial Update: Aspirin in Young Psychotic Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating aspirin in young patients with psychosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Clinic for Psychiatric Disorders, Dr Laza Lazarevic | Conditions: Psychosis, Acute Psychosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-09-23